Lipocine Inc (LPCN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 11,198 | -2,851 | 500 | 16,141 | 0 |
| Gross Profit | 11,198 | -2,851 | 500 | 16,141 | N/A |
| Operating Expenses | 12,353 | 15,080 | 12,619 | 12,995 | 17,996 |
| Operating Income | -1,155 | -17,931 | -12,119 | 3,146 | -17,996 |
| Interest Expense | 0 | 0 | 27 | 203 | 387 |
| Other Income | 1,164 | 1,580 | 1,389 | -3,576 | -2,582 |
| Pre-tax Income | 9 | -16,351 | -10,758 | -634 | -20,965 |
| Income Tax | 1 | 1 | -1 | 0 | 0 |
| Net Income Continuous | 8 | -16,352 | -10,757 | -634 | -20,965 |
| Net Income | $8 | $-16,352 | $-10,759 | $-634 | $-20,965 |
| EPS Basic Total Ops | 0.00 | -3.10 | -2.06 | -0.17 | -6.46 |
| EPS Basic Continuous Ops | 0.00 | -3.10 | -2.06 | -0.12 | -6.40 |
| EPS Diluted Total Ops | 0.00 | -3.14 | -2.15 | -0.17 | -6.46 |
| EPS Diluted Continuous Ops | 0.00 | -3.10 | -2.05 | -0.12 | -6.40 |
| EPS Diluted Before Non-Recurring Items | 0.00 | -3.14 | -2.21 | 0.68 | -6.46 |
| EBITDA(a) | $-1,812 | $-18,855 | $-12,232 | $3,662 | $-17,995 |